RhumbLine Advisers’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-3,462
| Closed | -$37K | – | 2939 |
|
|
2018
Q1 | $37K | Buy |
3,462
+13
| +0.4% | +$139 | ﹤0.01% | 2803 |
|
|
2017
Q4 | $145K | Sell |
3,449
-690
| -17% | -$29K | ﹤0.01% | 2716 |
|
|
2017
Q3 | $228K | Buy |
4,139
+75
| +2% | +$4.13K | ﹤0.01% | 2671 |
|
|
2017
Q2 | $754K | Buy |
4,064
+841
| +26% | +$156K | ﹤0.01% | 2098 |
|
|
2017
Q1 | $385K | Buy |
3,223
+114
| +4% | +$13.6K | ﹤0.01% | 2379 |
|
|
2016
Q4 | $309K | Buy |
3,109
+363
| +13% | +$36.1K | ﹤0.01% | 2482 |
|
|
2016
Q3 | $308K | Buy |
2,746
+62
| +2% | +$6.95K | ﹤0.01% | 2476 |
|
|
2016
Q2 | $276K | Buy |
2,684
+1,025
| +62% | +$105K | ﹤0.01% | 2579 |
|
|
2016
Q1 | $152K | Buy |
1,659
+96
| +6% | +$8.8K | ﹤0.01% | 2818 |
|
|
2015
Q4 | $225K | Buy |
+1,563
| New | +$225K | ﹤0.01% | 2739 |
|